Taylor Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Taylor Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.19M	Buy	+25,000	New	+$1.25M	0.78%	13

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Taylor Asset Management's BMY Position: Q1 2019 in Review

Taylor Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2019: 25,000 shares worth $1.19M. The stake represents 0.78% of the portfolio and ranks #13 among its holdings.

1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

Taylor Asset Management held 25,000 shares of Bristol-Myers Squibb worth $1.19M as of Q1 2019.
Bristol-Myers Squibb was a new Taylor Asset Management position in Q1 2019.
Bristol-Myers Squibb made up 0.78% of Taylor Asset Management's portfolio in Q1 2019, its #13 holding.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Taylor Asset Management's 13F filing for Q1 2019, filed 14 May 2019.